Adalvo

Adalvo and its partner CNX Therapeutics have launched their extended-release formulation of pregabalin in the UK as a first in the major European market. News of the launch follows a slew of pregabali

Central nervous system specialist CNX Therapeutics and Alvo group B2B arm Adalvo are claiming a UK and European first, after introducing their prolonged-release formulation of generic nitrofurantoin i

In a blowout year that saw three separate companies each achieve multiple honors, Sandoz emerged as the biggest winner of the Global Generics & Biosimilars Awards 2024, sponsored by IQVIA. Sandoz to

Adalvo is targeting a first-to-market opportunity, underscoring what it says is its commitment to addressing unmet medical needs in the rare disease segment, after submitting a filing in Europe via t